VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI • CA92847V5018
7.99 CAD
+0.15 (+1.91%)
Last: Feb 13, 2026, 07:00 PM
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 9 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- VHI had positive earnings in the past year.
- VHI had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
- Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.76%, VHI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- VHI has a better Return On Equity (1.08%) than 88.89% of its industry peers.
- With an excellent Return On Invested Capital value of 2.86%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 2.88%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- VHI's Operating Margin of 12.47% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
- In the last couple of years the Operating Margin of VHI has grown nicely.
- Looking at the Gross Margin, with a value of 80.92%, VHI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
- VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for VHI has been increased compared to 1 year ago.
- The number of shares outstanding for VHI has been increased compared to 5 years ago.
- The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
- VHI has an Altman-Z score of 3.44. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
- VHI has a Altman-Z score of 3.44. This is in the better half of the industry: VHI outperforms 66.67% of its industry peers.
- VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.13, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- With an excellent Debt to Equity ratio value of 0.00, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.44 |
ROIC/WACC0.33
WACC8.69%
2.3 Liquidity
- A Current Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
- The Current ratio of VHI (1.94) is better than 77.78% of its industry peers.
- A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
- The Quick ratio of VHI (1.94) is better than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
- The earnings per share for VHI have decreased strongly by -14.29% in the last year.
- Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
- The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
- Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 70.74% on average per year.
- VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.33% yearly.
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 133.17, VHI can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.19, VHI is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 32.96, the valuation of VHI can be described as expensive.
- VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
- VHI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 133.17 | ||
| Fwd PE | 32.96 |
4.2 Price Multiples
- 100.00% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.47 | ||
| EV/EBITDA | 17.55 |
4.3 Compensation for Growth
- VHI has a very decent profitability rating, which may justify a higher PE ratio.
- VHI's earnings are expected to grow with 70.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%
5. Dividend
5.1 Amount
- VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:VHI (2/13/2026, 7:00:00 PM)
7.99
+0.15 (+1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-16 2026-03-16
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap505.21M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.42 (92.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-0.6%
PT rev (3m)-2.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.29%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 133.17 | ||
| Fwd PE | 32.96 | ||
| P/S | 5.15 | ||
| P/FCF | 41.47 | ||
| P/OCF | 39.11 | ||
| P/B | 1.93 | ||
| P/tB | 10.26 | ||
| EV/EBITDA | 17.55 |
EPS(TTM)0.06
EY0.75%
EPS(NY)0.24
Fwd EY3.03%
FCF(TTM)0.19
FCFY2.41%
OCF(TTM)0.2
OCFY2.56%
SpS1.55
BVpS4.14
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.44 |
F-Score3
WACC8.69%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
What is the valuation status of VITALHUB CORP (VHI.CA) stock?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
Can you provide the financial health for VHI stock?
The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.